Skip to content
Congress·In Committee·3 months ago

House Bill Would Create National Biomanufacturing Center to Boost US Drug Production

Also known as: Biomanufacturing Excellence Act of 2025

Legislative Progress

✓ Filed
Review
House
Senate
President

Impacts

Mixed Impacts(5)
Chronic Illness
Neutral
Disability Benefits
Neutral
Housing Assistance
Neutral
Renter
Neutral
Homeowner
Neutral
Positive Impacts(2)
Student
Helps
Student Loans
Helps

Key Points

  • Congress would direct the National Institute of Standards and Technology to pick one non-federal group to run a national center focused on making medicines using living cells.
  • The center would work on “how to scale up” drug manufacturing—moving ideas from a lab into reliable, large-scale production—so the US is less dependent on foreign supply chains.
  • It would support better manufacturing standards and shared best practices, aiming to make new drug-making methods more consistent and easier for regulators to review.
  • It would help train workers—partnering with colleges and community groups—so more people can operate specialized biotech tools and equipment.
  • The bill authorizes $120 million for fiscal year 2026 to help build facilities, run research partnerships, and support training programs.
HealthcareTechnologyLabor EmploymentNational Security

Milestones

2 milestones2 actions
Nov 18, 2025House

Referred to the House Committee on Science, Space, and Technology.

Nov 18, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

Within 180 days after the bill becomes law

NIST starts the competition and asks universities/public-private partnerships to apply to run the Center

If you work at a university, lab, manufacturer, or training program, you may see partnership outreach and proposal activity; local leaders may lobby to bring the Center to their region

By 180 days after the bill becomes law

NIST selects one non-federal organization to receive the grant or agreement to set up the Center

One region and lead organization “wins” and can begin hiring, contracting, and planning facility buildout and training offerings

Months after the award, depending on site readiness and permits

Facility planning and construction (or expansion) begins using Center funds

Construction and local supplier work may ramp up near the chosen site; neighbors may notice more development activity

After the award, as partnerships are finalized

Training programs are launched with schools and community partners

People could see new certificate programs, hands-on equipment training, or employer-linked courses for biomanufacturing jobs

When the selected site is staffed and capable—timing depends on buildout

The Center begins operations and starts collaborative projects with manufacturers and researchers

Companies may begin using shared methods and facilities to test how to scale production; this can speed up U.S. manufacturing readiness over time

1 year after the award is made

NIST publishes the first public report on progress setting up the Center

The public can see where the Center is located, what is being built, and what partnerships are forming

1 year after operations begin

NIST publishes a report one year after operations officially begin

People can track what research, training, and manufacturing improvements are actually happening (not just plans)

5 years after operations begin

NIST publishes the final public report on outcomes

Congress and the public can judge whether the Center improved U.S. drug manufacturing capabilities and workforce training

Related News

2 articles
Fierce Pharma·3 months ago

Lawmakers dig in on biopharma manufacturing with bill proposing US center of excellence

Bipartisan lawmakers introduced the Biomanufacturing Excellence Act of 2025 to create a national center under NIST. The bill aims to reduce U.S. dependence on foreign supply chains and ensure a smoother road to commercialization through a public-private biopharmaceutical manufacturing hub.

C=
SSTI·about 2 months ago

Proposed biomanufacturing center may create competition among states

The proposed Biomanufacturing Excellence Act would establish a single National Biopharmaceutical Manufacturing Center of Excellence within NIST. With $120 million in authorized funding, the bill is expected to spark intense competition among states to host the new innovation and production hub.

C=

Source Information

Document Type

Congressional Bill

Official Title

Biomanufacturing Excellence Act of 2025

Bill NumberHR 6089
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Science, Space, and Technology.

Sponsor

Cosponsors

(12)
D: 6R: 6

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.